Carmichael Hill & Associates’s Corbus Pharmaceuticals CRBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $2.06K | Hold |
100
| – | – | ﹤0.01% | 595 |
|
|
2024
Q2 | $4.53K | Hold |
100
| – | – | ﹤0.01% | 547 |
|
|
2024
Q1 | $3.92K | Hold |
100
| – | – | ﹤0.01% | 556 |
|
|
2023
Q4 | $604 | Hold |
100
| – | – | ﹤0.01% | 651 |
|
|
2023
Q3 | $674 | Hold |
100
| – | – | ﹤0.01% | 637 |
|
|
2023
Q2 | $784 | Hold |
100
| – | – | ﹤0.01% | 640 |
|
|
2023
Q1 | $727 | Hold |
100
| – | – | ﹤0.01% | 639 |
|
|
2022
Q4 | $332 | Hold |
100
| – | – | ﹤0.01% | 643 |
|
|
2022
Q3 | $0 | Hold |
100
| – | – | ﹤0.01% | 713 |
|
|
2022
Q2 | $1K | Hold |
100
| – | – | ﹤0.01% | 641 |
|
|
2022
Q1 | $2K | Hold |
100
| – | – | ﹤0.01% | 625 |
|
|
2021
Q4 | $2K | Hold |
100
| – | – | ﹤0.01% | 629 |
|
|
2021
Q3 | $3K | Hold |
100
| – | – | ﹤0.01% | 607 |
|
|
2021
Q2 | $5K | Hold |
100
| – | – | ﹤0.01% | 554 |
|
|
2021
Q1 | $6K | Buy |
100
+67
| +203% | +$4.02K | ﹤0.01% | 522 |
|
|
2020
Q4 | $1K | Hold |
33
| – | – | ﹤0.01% | 608 |
|
|
2020
Q3 | $2K | Hold |
33
| – | – | ﹤0.01% | 561 |
|
|
2020
Q2 | $8K | Hold |
33
| – | – | 0.01% | 435 |
|
|
2020
Q1 | $5K | Hold |
33
| – | – | ﹤0.01% | 452 |
|
|
2019
Q4 | $5K | Buy |
+33
| New | +$5K | ﹤0.01% | 486 |
|